Use of Antiepileptic Medications in Pregnancy in Relation to Risks of Birth Defects

Overview of attention for article published in Annals of Epidemiology, November 2011

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (90th percentile)
High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

policy: 2 policy sources
twitter: 1 X user

guideline: 2 clinical guideline sources

Readers on

mendeley: 120 Mendeley
citeulike: 2 CiteULike

So far, Altmetric has seen 6 policy documents that reference this research output.

Folic acid antagonist use before and during pregnancy and risk for selected birth defects

Cited by Centers for Disease Control and Prevention (CDC) on 14 Mar 2024

CDC is America’s leading public health agency, dedicated to saving and protecting the health of Americans. CDC monitors health, informs decisionmakers, and provides people with information so they can take responsibility for their own health.

Quantification of selection bias in studies of risk factors for birth defects among live births

Cited by Centers for Disease Control and Prevention (CDC) on 01 Nov 2020

Atypical Antipsychotic Use during Pregnancy and Birth Defect Risk: National Birth Defects Prevention Study, 1997–2011

Cited by Centers for Disease Control and Prevention (CDC) on 01 Jan 2020

Antenatal and postnatal mental health: clinical management and service guidance : Full guideline

Cited by National Institute for Health and Care Excellence (NICE) on 28 Nov 2014

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.

This page shows the most recent policy documents that mention this research output. Click here to find out how to access more activity, including 2 additional policy documents.